{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-23-007651","form_type":"8-K","ticker":"BGLC","cik":"0001737523","company_name":"BioNexus Gene Lab Corp","filed_at":"2023-10-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.264118+00:00","generated_at":"2026-06-09T23:26:44.783049+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Bionexus Gene Lab appoints Chi Yuen Leong as CEO and director, effective Oct 12, 2023","bullets":["Chi Yuen Leong appointed CEO and director effective October 12, 2023; annual compensation $24,000.","Leong previously served as President and director from company inception to August 2022.","He has no family relationships or reportable transactions with the company.","Leong brings experience from CEO role at US Arem Pacific Corp (2009-2015) and background in biotechnology."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-23-007651","json":"https://secwatch.observer/filing/0001477932-23-007651.json","markdown":"https://secwatch.observer/filing/0001477932-23-007651.md","text":"https://secwatch.observer/filing/0001477932-23-007651.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1737523/000147793223007651/0001477932-23-007651-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1737523/000147793223007651/bglc_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T23:26:44.783049+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"393ee5a138","claim":"Chi Yuen Leong was appointed as Chief Executive Officer at BioNexus Gene Lab Corp.","evidence_excerpt":"On October 12, 2023, the board of directors of the Bionexus Gene Lab Corp. (“the Company”) approved the appointment of Mr. Chi Yuen Leong as the Chief Executive Officer and a director, effective October 12, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1737523/000147793223007651/0001477932-23-007651-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"396826f8af","claim":"Chi Yuen Leong was appointed as Director at BioNexus Gene Lab Corp.","evidence_excerpt":"On October 12, 2023, the board of directors of the Bionexus Gene Lab Corp. (“the Company”) approved the appointment of Mr. Chi Yuen Leong as the Chief Executive Officer and a director, effective October 12, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1737523/000147793223007651/0001477932-23-007651-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}